Related Experiment Videos
CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6
1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City 84132.
Abstract:
Regulated adherence of polymorphonuclear leukocytes (PMNs) to endothelium and subendothelial matrix is a critical event for PMN localization at and migration into inflammatory sites. We previously reported that human PMNs stimulated in vitro adhere to laminin, the major glycoprotein of mammalian basement membrane, by both CD11/CD18 (beta 2 integrin)-dependent and CD11/CD18-independent mechanisms. This CD11/CD18-independent adherence is inhibited by monoclonal antibodies (MoAbs) directed against the beta 1 subunit of integrins (very late antigens [VLA]). The specific PMN VLA receptor responsible for stimulated CD11/CD18-independent PMN adherence to laminin was not elucidated. We show here that this CD11/CD18-independent adherence is mediated by a member of the beta 1 integrins, VLA-6. MoAbs GoH3 and 450-30, which bind the alpha 6 subunit of VLA-6, significantly reduced adherence of phorbol myristate acetate-stimulated PMNs to laminin-coated surfaces when CD11/CD18-independent adherence was blocked with anti-CD11/CD18 MoAbs. Furthermore, GoH3 completely inhibited stimulated adherence of CD11/CD18-deficient PMNs to laminin. Analysis by flow cytometry showed that human PMNs express VLA-6. The PMN alpha 6 is identical in size and pl to the platelet alpha 6, but the PMN beta 1 exhibits considerable heterogeneity in molecular weight compared with the platelet beta 1. This activation-dependent adherence receptor for laminin may play a role in PMN interaction with basement membrane laminin during PMN movement through vascular walls.
Insights
Polymorphonuclear leukocytes (PMNs) use VLA-6, a beta 1 integrin, for CD11/CD18-independent adherence to laminin. This finding clarifies a key mechanism in PMN migration during inflammation.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Polymorphonuclear leukocytes (PMNs) adhere to endothelium and matrix for inflammatory site localization.
- Previous studies showed PMN adherence to laminin involves CD11/CD18-dependent and -independent pathways.
- The CD11/CD18-independent pathway is inhibited by anti-beta 1 integrin antibodies (VLA).
Purpose of the Study:
- To identify the specific VLA receptor mediating CD11/CD18-independent PMN adherence to laminin.
- To elucidate the role of VLA-6 in PMN-laminin interactions.
Main Methods:
- Used monoclonal antibodies (MoAbs) against VLA-6 alpha 6 subunit (GoH3 and 450-30).
- Assessed adherence of phorbol myristate acetate-stimulated PMNs to laminin-coated surfaces.
- Analyzed adherence in CD11/CD18-deficient PMNs.
- Utilized flow cytometry to detect VLA-6 expression on human PMNs.
Main Results:
- MoAbs targeting VLA-6 significantly reduced adherence of stimulated PMNs to laminin when CD11/CD18-independent adherence was blocked.
- VLA-6 (GoH3) completely inhibited adherence in CD11/CD18-deficient PMNs.
- Human PMNs express VLA-6, with distinct beta 1 subunit characteristics compared to platelets.
Conclusions:
- VLA-6 is the primary receptor mediating CD11/CD18-independent PMN adherence to laminin.
- This interaction is crucial for PMN localization and migration into inflammatory sites.
- VLA-6 may play a significant role in PMN transmigration through basement membranes.